348 related articles for article (PubMed ID: 19113922)
1. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.
Binkley N; Harke J; Krueger D; Engelke J; Vallarta-Ast N; Gemar D; Checovich M; Chappell R; Suttie J
J Bone Miner Res; 2009 Jun; 24(6):983-91. PubMed ID: 19113922
[TBL] [Abstract][Full Text] [Related]
2. Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats.
Binkley N; Krueger D; Engelke J; Crenshaw T; Suttie J
Bone; 2002 Jun; 30(6):897-900. PubMed ID: 12052460
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
[TBL] [Abstract][Full Text] [Related]
4. Effect of phylloquinone (vitamin K1) supplementation for 12 months on the indices of vitamin K status and bone health in adult patients with Crohn's disease.
O'Connor EM; Grealy G; McCarthy J; Desmond A; Craig O; Shanahan F; Cashman KD
Br J Nutr; 2014 Oct; 112(7):1163-74. PubMed ID: 25181575
[TBL] [Abstract][Full Text] [Related]
5. Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (vitamin K(1)) or menaquinone-7 (vitamin K (2)): the Postmenopausal Health Study II.
Kanellakis S; Moschonis G; Tenta R; Schaafsma A; van den Heuvel EG; Papaioannou N; Lyritis G; Manios Y
Calcif Tissue Int; 2012 Apr; 90(4):251-62. PubMed ID: 22392526
[TBL] [Abstract][Full Text] [Related]
6. Effects of vitamin K in postmenopausal women: mini review.
Guralp O; Erel CT
Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K, bone turnover, and bone mass in girls.
Kalkwarf HJ; Khoury JC; Bean J; Elliot JG
Am J Clin Nutr; 2004 Oct; 80(4):1075-80. PubMed ID: 15447922
[TBL] [Abstract][Full Text] [Related]
8. Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.
Bügel S; Sørensen AD; Hels O; Kristensen M; Vermeer C; Jakobsen J; Flynn A; Mølgaard C; Cashman KD
Br J Nutr; 2007 Feb; 97(2):373-80. PubMed ID: 17298708
[TBL] [Abstract][Full Text] [Related]
9. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
Kruger MC; Booth CL; Coad J; Schollum LM; Kuhn-Sherlock B; Shearer MJ
Nutrition; 2006; 22(11-12):1120-8. PubMed ID: 17030114
[TBL] [Abstract][Full Text] [Related]
10. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.
Bolton-Smith C; McMurdo ME; Paterson CR; Mole PA; Harvey JM; Fenton ST; Prynne CJ; Mishra GD; Shearer MJ
J Bone Miner Res; 2007 Apr; 22(4):509-19. PubMed ID: 17243866
[TBL] [Abstract][Full Text] [Related]
11. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
Inoue T; Sugiyama T; Matsubara T; Kawai S; Furukawa S
Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women.
Volpe SL; Leung MM; Giordano H
Nutr Res; 2008 Sep; 28(9):577-82. PubMed ID: 19083462
[TBL] [Abstract][Full Text] [Related]
13. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults.
Binkley NC; Krueger DC; Engelke JA; Foley AL; Suttie JW
Am J Clin Nutr; 2000 Dec; 72(6):1523-8. PubMed ID: 11101481
[TBL] [Abstract][Full Text] [Related]
15. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
[TBL] [Abstract][Full Text] [Related]
16. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E
Osteoporos Int; 2013 Sep; 24(9):2499-507. PubMed ID: 23525894
[TBL] [Abstract][Full Text] [Related]
17. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.
Shiraki M; Itabashi A
J Bone Miner Metab; 2009; 27(3):333-40. PubMed ID: 19172219
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K₂ therapy for postmenopausal osteoporosis.
Iwamoto J
Nutrients; 2014 May; 6(5):1971-80. PubMed ID: 24841104
[TBL] [Abstract][Full Text] [Related]
19. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
20. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
Miller PD; Chines AA; Christiansen C; Hoeck HC; Kendler DL; Lewiecki EM; Woodson G; Levine AB; Constantine G; Delmas PD
J Bone Miner Res; 2008 Apr; 23(4):525-35. PubMed ID: 18072873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
